Intestinal Research

Inflammatory bowel diseases
A glycolipid adjuvant, 7DW8-5, provides a protective effect against colonic inflammation in mice by the recruitment of CD1d-restricted natural killer T cells: Chansu Lee, Sung Noh Hong, Young-Ho Kim; Intest Res. 2020;18(4):402-411. Published online April 8, 2020; DOI: https://doi.org/10.5217/ir.2019.00132
Web of Science 4 Crossref 4; Full text PubReader ePub PDF Supplementary Material

Fibrostenotic strictures in Crohn’s disease: Jun Hwan Yoo, Stefan Holubar, Florian Rieder; Intest Res. 2020;18(4):379-401. Published online April 10, 2020; DOI: https://doi.org/10.5217/ir.2019.09148
Web of Science 42 Crossref 44; Full text PubReader ePub PDF

Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease: Ajit Sood, Vineet Ahuja, Vandana Midha, Saroj Kant Sinha, C. Ganesh Pai, Saurabh Kedia, Varun Mehta, Sawan Bopanna, Philip Abraham, Rupa Banerjee, Shobna Bhatia, Karmabir Chakravartty, Sunil Dadhich, Devendra Desai, Manisha Dwivedi, Bhabhadev Goswami, Kirandeep Kaur, Rajeev Khosla, Ajay Kumar, Ramit Mahajan, S. P. Misra, Kiran Peddi, Shivaram Prasad Singh, Arshdeep Singh; Intest Res. 2020;18(4):355-378. Published online July 13, 2020; DOI: https://doi.org/10.5217/ir.2019.09176
Web of Science 12 Crossref 12; Full text PubReader ePub PDF

Clinical management for small bowel of Crohn’s disease in the treat-to-target era: now is the time to optimize treatment based on the dominant lesion: Kenji Watanabe; Intest Res. 2020;18(4):347-354. Published online October 26, 2020; DOI: https://doi.org/10.5217/ir.2020.00032
Web of Science 21 Crossref 21; Full text PubReader ePub PDF

The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia: Seung Wook Hong, Byong Duk Ye; Intest Res. 2020;18(4):345-346. Published online October 26, 2020; DOI: https://doi.org/10.5217/ir.2020.00121
Web of Science 12 Crossref 12; Full text PubReader ePub PDF

Sausage-like fingers in Crohn’s disease: Akira Hokama, Taiga Miyagi, Yukiko Takeichi, Eriko Uema, Sayuri Takehara, Tetsuya Ohira, Atsushi Iraha, Tetsu Kinjo, Jiro Fujita; Intest Res. 2020;18(3):341-342. Published online May 25, 2020; DOI: https://doi.org/10.5217/ir.2020.00036; Full text PubReader ePub PDF

Incidental benefits after fecal microbiota transplant for ulcerative colitis: Ramit Mahajan, Vandana Midha, Arshdeep Singh, Varun Mehta, Yogesh Gupta, Kirandeep Kaur, Ritu Sudhakar, Anmol Singh Pannu, Dharmatma Singh, Ajit Sood; Intest Res. 2020;18(3):337-340. Published online April 22, 2020; DOI: https://doi.org/10.5217/ir.2019.00108
Web of Science 9 Crossref 9; Full text PubReader ePub PDF

Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease: Saad Alrajhi, Pascale Germain, Myriam Martel, Peter Lakatos, Talat Bessissow, Talal Al-Taweel, Waqqas Afif; Intest Res. 2020;18(3):306-314. Published online March 20, 2020; DOI: https://doi.org/10.5217/ir.2019.00116
Web of Science 10 Crossref 9; Full text PubReader ePub PDF Supplementary Material

Hypermethylated promoters of tumor suppressor genes were identified in Crohn’s disease patients: Tae-Oh Kim, Yu Kyeong Han, Joo Mi Yi; Intest Res. 2020;18(3):297-305. Published online February 7, 2020; DOI: https://doi.org/10.5217/ir.2019.00105
Web of Science 7 Crossref 7; Full text PubReader ePub PDF

Presentation and outcomes among inflammatory bowel disease patients with concurrent pneumatosis intestinalis: a case series and systematic review: Youran Gao, Meka Uffenheimer, Michael Ashamallah, Gregory Grimaldi, Arun Swaminath, Keith Sultan; Intest Res. 2020;18(3):289-296. Published online November 4, 2019; DOI: https://doi.org/10.5217/ir.2019.00073
Web of Science 6 Crossref 9; Full text PubReader ePub PDF

Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancy: Hiep Phan, Rick A. Weideman, Daisha J. Cipher, Linda A. Feagins; Intest Res. 2020;18(3):282-288. Published online April 7, 2020; DOI: https://doi.org/10.5217/ir.2019.09140
Web of Science 10 Crossref 8; Full text PubReader ePub PDF

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease: Katsuyoshi Matsuoka; Intest Res. 2020;18(3):275-281. Published online June 3, 2020; DOI: https://doi.org/10.5217/ir.2020.00002
Web of Science 26 Crossref 26; Full text PubReader ePub PDF

Capsule endoscopy in inflammatory bowel disease: when and how: Ida Hilmi, Taku Kobayashi; Intest Res. 2020;18(3):265-274. Published online July 7, 2020; DOI: https://doi.org/10.5217/ir.2019.09165
Web of Science 11 Crossref 12; Full text PubReader ePub PDF

Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases: Jung Min Kim, Jae Hee Cheon; Intest Res. 2020;18(3):249-264. Published online April 18, 2020; DOI: https://doi.org/10.5217/ir.2019.00128
Web of Science 40 Crossref 38; Full text PubReader ePub PDF

Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?: Gyu Man Oh, Won Moon; Intest Res. 2020;18(3):245-246. Published online July 20, 2020; DOI: https://doi.org/10.5217/ir.2020.00061
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

IBD